Skip to content

IPSC

Century Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$2.19-2.67%

Price as of Jul 20, 2026

IPSC capital

Century Therapeutics, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.18x
Net debt / equity
-0.01x
Debt / assets
0.15x
Debt / EBITDA
-0.53x
Net debt / EBITDA
0.03x

Liquidity & coverage

Current ratio
10.25x
Quick ratio
10.25x
Cash ratio
9.94x
Interest coverage
EBITDA / interest
Working capital
$125.5M

Cash & dividend

FCF / debt
-2.00x
Cash flow / debt
-1.97x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.